NCT00195013View on ClinicalTrials.gov

Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Peripheral NeuropathyBreast Cancer
Interventions
DRUG

glutamine

10 grams three times a day (orally) for four days and then stop

DRUG

Placebo

10 grams three times a day (orally) for four days and then stop

Trial Locations (1)

10021

Weill Medical College of Cornell University, New York

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER

NCT00195013 - Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy | Biotech Hunter | Biotech Hunter